1. Hepatotoxicity of high dose salicylate therapy in acute rheumatic fever.
- Author
-
Singh H, Chugh JC, Shembesh AH, Ben-Musa AA, and Mehta HC
- Subjects
- Acute Disease, Adolescent, Aspirin administration & dosage, Aspirin therapeutic use, Child, Child, Preschool, Dose-Response Relationship, Drug, Female, Humans, Liver cytology, Liver drug effects, Liver metabolism, Liver Diseases metabolism, Liver Function Tests, Male, Prospective Studies, Rheumatic Fever blood, Aspirin adverse effects, Chemical and Drug Induced Liver Injury, Rheumatic Fever drug therapy
- Abstract
Liver function tests, including serum alanine aminotransferase (ALT) activity, serum bilirubin, alkaline phosphatase, serum proteins, blood ammonia levels and intravenous glucose utilization, were monitored in 50 children with acute rheumatic fever receiving anti-rheumatic doses of aspirin. There was a significant increase in blood ammonia levels and serum ALT after aspirin therapy. A significant fall in glucose utilization coefficient was also recorded. Serum alkaline phosphatase, bilirubin and total proteins did not change significantly. Twenty-two of the 50 children recorded a rise in serum ALT; in 12, the rise was five- to tenfold. These 12 children developed adverse symptoms to aspirin. Also, all had a marked rise in blood ammonia levels. The children improved clinically and biochemically on withdrawal of aspirin. There was no constant relationship between hepatocellular function and serum salicylate levels.
- Published
- 1992
- Full Text
- View/download PDF